VY2024-03 Enrolling

Plaque Psoriasis Study (20 Weeks)


Treatment: Oral


Who Can Participate?

Anybody aged between 18 and 75 years with moderate to severe PsO may participate.

Inclusion Criteria

• have a body mass index of 18 to 40 kg/m2
• have a total body weight > 40 kg
• have a clinical diagnosis of plaque psoriasis for ≥ 6 months

Participant Information

• Participate and receive study treatment at no cost
• Regular visits with study doctors who specialize in treating plaque psoriasis (9 visits)
• Will receive an investigative oral treatment (study drug) or a placebo
• Reimbursement for study-related expenses may be provided

How Long Will The Study Last?

20 weeks


Participating Locations

COUNTRY
country-icon
United States
country-icon
Canada

Participating Experts

No Doctors Found

You May Also Be Interested In

Similar Trials

No Similar Trials Found

The following information is from ClinicalTrials.gov

Last Update Posted: February 06, 2025

Sponsor

Vyne Therapeutics


Terms and Conditions – ClinicalTrials.gov
Purpose of ClinicalTrials.gov Database. The U.S. National Institutes of Health, Department of Health and Human Services, through its National Library of Medicine, has developed ClinicalTrials.gov to provide patients, family members, and members of the public current information about clinical research studies.



about-icon

Learn More About

Psoriasis

Learn More
2025 all rights reserved Probity Medical Research Inc
find a trial
General Registration

Can’t find a trial? Not sure which trial to choose? Complete a general registration and we’ll contact you with suitable trials.

Register
filter trials
Skip to content